Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Die 3-Milliarden-Dollar-Frage: Wird Foremost das nächste Denison?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
244 Leser
Artikel bewerten:
(1)

Providence St. Joseph Hospital Performs World's First Spine Surgery Using eCential Robotics' Open Spine Robot, with Spineart Compatible Implants

FOR IMMEDIATE RELEASE

Providence St. Joseph Hospital Performs World's First Spine Surgery Using eCential Robotics' Open Spine Robot, with Spineart Compatible Implants

ORANGE, Calif. July 25, 2024 - Providence St. Joseph Hospital announced it has successfully performed the world's first robotic spinal surgery using a new open spine platform by eCential Roboticsto implant a Spineartmedical device.

eCential Robotics, a surgical robotics company which developed the open surgical platform and Spineart, a leader in spine surgery innovation, are collaborators in a new age of open technology sharing that allows cross-functional use of implantation devices and robotic surgical platforms.

"In our relentless pursuit of innovation and excellence in patient care, we were eager to utilize the solutions provided by Spineart and eCential," said Erick Westbroek*, M.D., Providence St. Joseph spinal surgeon. "The integration of Spineart's advanced implant system with eCential's open robotic platform will enable us to perform minimally invasive surgeries with high predictability, reproducibility and outcomes."

Providence St. Joseph Hospital has become the first clinical institution in the world to be equipped with the state-of-the-art robot, and the recent surgeries are the first in the United States to be used successfully in conjunction with Spineart implants.

"St. Joseph Hospital has built a strong reputation for world-class surgical care, and our patients often travel from far and wide to seek treatment and care from our stellar spine and orthopedic surgeons, who are armed with cutting-edge technology," said Brian Helleland, chief executive of Providence St. Joseph Hospital and the Orange County/High Desert area. "These advances provide yet another sophisticated platform for our surgeons to do what they do best."

"We are thrilled to announce the installation of this state-of-the-art robot at St. Joseph Hospital," said Jerome Trividic, CEO of Spineart. "We believe this advancement will greatly benefit our customers, hospitals, surgeons, and patients by enhancing surgical precision and improving patient outcomes."

St. Joseph's surgical cases for eCential Robotics are a first-in-human use of its unified robotic technology, as well as the start of eCential operations in the US. It also marks the introduction of cutting-edge solutions that address the evolving needs of surgeons and patients worldwide.

"We are pleased to see the adoption of our technology in the US," Clément Vidal, CEO of eCential Robotics. "There is strong interest and momentum for our open solution because it allows surgeons to select the optimal implant system for each patient while providing financial advantages to hospitals. Our platform is described as the smartphone of surgical robots."

###

About Providence St. Joseph Hospital
Providence St. Joseph Hospital in Orange, California is a nationally recognized, 463-bed, not-for-profit Catholic hospital founded in 1929 by the Sisters of St. Joseph of Orange. Fully accredited by The Joint Commission and designated as a Magnet hospital for nursing excellence, St. Joseph Hospital's reputation for clinical excellence and compassionate, family-centered care draws patients from all over the United States. St. Joseph Hospital is part of Providence, a health system serving in 52 hospitals with a comprehensive range of services across Alaska, California, Montana, New Mexico, Oregon, Texas and Washington. For more information visit:providence.org/stjoseph.

About Spineart
Spineart is a global fast-growing company in spine surgery innovation, dedicated to accelerating the adoption of cutting-edge technologies for surgeons and hospitals worldwide for the benefit of their patients. Renowned for its commitment to Quality, Innovation, and Simplicity, Spineart continues to push the boundaries of spinal surgery with its comprehensive portfolio of procedural solutions and digital technologies. Spineart was awarded the "Prix de l'Economie Genevoise 2022" for its contribution to technological and scientific innovations, commercial activities, job creations and ESG principles.

Please visit www.spineart.com and follow on LinkedIn. For media inquiries or further information, please contact press@spineart.com

About eCential Robotics
eCential Robotics is a French and US-based company, founded by Stéphane Lavallée and part of the Grenoble Haventure network, specializing in surgical robotics. It has developed an open, unified yet modular and scalable 2D/3D imaging, navigation, and robotic platform aiming to improve bone surgery outcomes. With more than 100 patents and 7 trademarks, eCential Robotics is pursuing a disruptive innovation strategy, enabling third parties to integrate their implants with the platform and develop surgical Apps in its ecosystem. Thanks to multiple partnerships already established with implant manufacturers, tech companies, and research labs, eCential Robotics is positioned as a leader in the fast-growing surgical robotics market and aspires to become the world leader in open robotic platforms.

Please visit www.ecential-robotics.com and follow on LinkedIn (eCential Robotics)

Media contact Investor relations
Matthieu VILLE Benjamin COLAS
matthieu.ville@ecential-robotics.com benjamin.colas@ecential-robotics.com

* Dr. Erick Westbroek is a paid consultant of Spineart. His statements represent his own opinions based on personal experience and are not necessarily those of Spineart.


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.